These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Lee RU; White AA; Ding D; Dursun AB; Woessner KM; Simon RA; Stevenson DD Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823 [TBL] [Abstract][Full Text] [Related]
26. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879 [TBL] [Abstract][Full Text] [Related]
27. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day]. Gosepath J; Schäfer D; Mann WJ Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524 [TBL] [Abstract][Full Text] [Related]
28. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease. Waldram JD; Simon RA Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764 [TBL] [Abstract][Full Text] [Related]
29. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial. Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948 [TBL] [Abstract][Full Text] [Related]
30. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy. Pfaar O; Klimek L J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950 [TBL] [Abstract][Full Text] [Related]
31. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease. Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E Front Immunol; 2021; 12():695815. PubMed ID: 34305932 [TBL] [Abstract][Full Text] [Related]
32. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold? O'Brien EK; Jerschow E; Divekar RD Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102 [TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156 [TBL] [Abstract][Full Text] [Related]
34. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease. Woessner KM; White AA J Allergy Clin Immunol; 2014 Jan; 133(1):286-7.e1-9. PubMed ID: 24369807 [No Abstract] [Full Text] [Related]
35. Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients. Shah SJ; Abuzeid WM; Ponduri A; Pelletier T; Ren Z; Keskin T; Roizen G; Rosenstreich D; Ferastraoaru D; Jerschow E Int Forum Allergy Rhinol; 2019 Dec; 9(12):1401-1408. PubMed ID: 31569308 [TBL] [Abstract][Full Text] [Related]
36. Algorithmic Identification of Patients With Aspirin-Exacerbated Respiratory Disease Using an Electronic Health Record. Tao M; Roberts S; Arnold M Otolaryngol Head Neck Surg; 2023 Aug; 169(2):253-257. PubMed ID: 36939473 [TBL] [Abstract][Full Text] [Related]
37. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data. San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease. Hill J; Burnett T; Katial R Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767 [TBL] [Abstract][Full Text] [Related]
39. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology. Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116 [TBL] [Abstract][Full Text] [Related]
40. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. Williams AN; Woessner KM Curr Allergy Asthma Rep; 2008 May; 8(3):245-52. PubMed ID: 18589844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]